Therapy cessation: FDA reporting patterns
50,418 FDA FAERS reports mention Therapy cessation. 22,445 reports have a serious outcome flag.
Medicines named as suspect
- Dalfampridine: 4,601 reports
- Etanercept: 2,090 reports
- Adalimumab: 1,900 reports
- Abiraterone: 1,612 reports
- Voxelotor: 1,038 reports
- Clozapine: 921 reports
- Lomitapide: 831 reports
- Treprostinil: 779 reports
- Capecitabine: 762 reports
- Isotretinoin: 700 reports
- Secukinumab: 627 reports
- Tofacitinib: 602 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.